Theraclion
Malakoff
About Theraclion
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins. Their companyTheraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Feb 2025)
- Ticker: epa:ALTHE
- Website: theraclion.com
- Phone: +33155489070
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/theraclion-198805 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.